Trial Profile
Efficacy of Tetrahydrobiopterin (BH4) in Responsive Phenylketonuria Patient Administered in two Divided Doses Versus a Single Daily Dose
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Sapropterin (Primary)
- Indications Phenylketonuria
- Focus Therapeutic Use
- 10 May 2018 New trial record